Precision Neuroscience Funding: $180M Raised, Series C

Precision Neuroscience funding overview

Precision Neuroscience is a Biotech company based in New York City, Country. Precision Neuroscience has raised $180M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in December 2024. The round record for Precision Neuroscience runs through 2024; nothing later has been disclosed. Investors on record include General Equity Holdings, B Capital, Duquesne Family Office, Steadview Capital, SCI Ventures, Stanley Druckenmiller's investment firm. 6 distinct backers are named across the disclosed rounds.

Precision Neuroscience at a glance

Total raised: $180M
Latest round: Series C
Latest round date: December 2024
Industry: Biotech
Headquarters: New York City, Country
Notable investors: General Equity Holdings, B Capital, Duquesne Family Office, Steadview Capital, SCI Ventures, Stanley Druckenmiller's investment firm

Frequently asked about Precision Neuroscience funding

How much has Precision Neuroscience raised?: Precision Neuroscience has raised $180M in total disclosed funding across the rounds on record.
Who has invested in Precision Neuroscience?: General Equity Holdings, B Capital, Duquesne Family Office, Steadview Capital, SCI Ventures, Stanley Druckenmiller's investment firm are named among the investors backing Precision Neuroscience.
What was the latest Precision Neuroscience funding round?: The most recent disclosed round is a Series C, announced in December 2024.
Where is Precision Neuroscience based?: Precision Neuroscience is based in New York City, Country.
What sector does Precision Neuroscience operate in?: Precision Neuroscience is tracked under Biotech from New York City, Country, with $180M in disclosed funding.
When did Precision Neuroscience last raise?: The last disclosed Precision Neuroscience round closed in December 2024 at Series C.

Precision Neuroscience totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in New York City below to benchmark round size and investor mix.

Precision Neuroscience Funding: $180M Raised, Series C

Precision Neuroscience funding overview

Precision Neuroscience at a glance

Frequently asked about Precision Neuroscience funding

Companies related to Precision Neuroscience (35)

Browse related funding lists (5)